ClinConnect ClinConnect Logo
Search / Trial NCT06362824

Promoting Physical Activity in Older Hispanic/Latino(a) Adults

Launched by KAISER PERMANENTE · Apr 8, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called "Promoting Physical Activity in Older Hispanic/Latino(a) Adults," is studying how a special program can help older Hispanic and Latino adults become more active and improve their overall health. The researchers are looking for 130 participants aged 55 to 89 who do not have dementia. Participants will be randomly assigned to one of two groups: one group will receive a culturally adapted physical activity program called De Pie, while the other will take part in a program focused on general brain health. The goal is to see if the De Pie program can help participants feel more confident and motivated to engage in physical activity, aiming for at least 150 minutes of moderate exercise each week over 12 weeks.

To be eligible for the study, participants must identify as Hispanic or Latino, be able to walk unaided for at least one block, and have access to a smartphone. They should be comfortable communicating in either Spanish or English and be available for study calls on weekdays. Participants will wear a device to track their activity for a couple of weeks and complete some questionnaires. It's important to note that individuals who are very active, have certain health conditions, or have plans that might interfere with the study won't be able to participate. This trial offers an exciting opportunity for older adults to improve their physical health in a supportive and culturally relevant way.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • be 55-89 and self-identify as Hispanic/Latino(a)
  • able to participate for up to 20 weeks in the study
  • willing to be randomized to the intervention or active comparison program
  • willing to follow study procedures depending on program assignment
  • available M-F for study phone calls between 8am-5pm
  • able to walk one block unassisted,
  • able to speak and can read Spanish or English,
  • have a smartphone (85% of the Hispanic/Latino(a) population has a smartphone)
  • willing to wear an ActiGraph for up to 2 weeks, twice during the course of the study
  • willing to complete study questionnaires via weblink, paper, or phone call
  • have an email address and be willing to share it with the team
  • have a US mailing address where they receive mail regularly (confirmed in pre-screen)
  • Exclusion criteria are as follows:
  • score less than or equal to 4 on the Six-Item Screener (Callahan et al., 2002)
  • unable to hear phone conversation, even with a hearing aid
  • planned surgeries or travel that would interfere with participation
  • had a fall in the last year that resulted in hospitalization
  • had a cancer diagnosis that requires treatment in the past year (other than skin cancer)
  • had a diagnosis of heart attack or irregular heart beat (arrythmia) in the past year
  • been advised recently by their doctor to avoid physical activity
  • does not want to share cognitive health information collected during the study with researchers at UCSD
  • unwilling to share their email address
  • unwilling to obtain an email address if they do not already have one
  • currently participating in another institution's physical activity study

About Kaiser Permanente

Kaiser Permanente is a leading integrated health care organization that combines a health plan with a network of hospitals and physicians to provide comprehensive medical services. With a strong commitment to advancing medical research and improving patient care, Kaiser Permanente sponsors clinical trials across various therapeutic areas. The organization emphasizes innovative approaches to health care, leveraging its extensive data and resources to support evidence-based treatments and enhance patient outcomes. Through its rigorous research initiatives, Kaiser Permanente aims to contribute to the advancement of medical knowledge and the development of new therapies that benefit diverse populations.

Locations

San Diego, California, United States

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Dori E Rosenberg, PhD, MPH

Principal Investigator

Kaiser Permanente

Zvinka Z Zlatar, PhD

Principal Investigator

University of California, San Diego

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported